A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

2536

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Obesity

Interventions

DRUG: CP-945,598 Treatment A
DRUG: CP-945,598 Treatment B
DRUG: Placebo

Sponsor

Pfizer